中山醫學大學機構典藏 CSMUIR:Item 310902500/25041
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 17938/22957 (78%)
造访人次 : 7412639      在线人数 : 164
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/25041


    题名: New insights into antimetastatic signaling pathways of melatonin in skeletomuscular sarcoma of childhood and adolescence
    作者: Lu, KH;Lin, CW;Hsieh, YH;Su, SC;Reiter, RJ;Yang, SF
    关键词: Adolescence;Childhood;Melatonin;Metastasis;Sarcoma
    日期: 2020
    上传时间: 2022-08-09T09:27:28Z (UTC)
    出版者: SPRINGER
    ISSN: 0167-7659
    摘要: Melatonin is an indole produced by the pineal gland at night under normal light or dark conditions, and its levels, which are higher in children than in adults, begin to decrease prior to the onset of puberty and continue to decline thereafter. Apart from circadian regulatory actions, melatonin has significant apoptotic, angiogenic, oncostatic, and antiproliferative effects on various cancer cells. Particularly, the ability of melatonin to inhibit skeletomuscular sarcoma, which most commonly affects children, teenagers, and young adults, is substantial. In the past few decades, the vast majority of references have focused on the concept of epithelial-mesenchymal transition involvement in invasion and migration to allow carcinoma cells to dissociate from each other and to degrade the extracellular matrix. Recently, researchers have applied this idea to sarcoma cells of mesenchymal origin, e.g., osteosarcoma and Ewing sarcoma, with their ability to initiate the invasion-metastasis cascade. Similarly, interest of the effects of melatonin has shifted from carcinomas to sarcomas. Herein, in this state-of-the-art review, we compiled the knowledge related to the molecular mechanism of antimetastatic actions of melatonin on skeletomuscular sarcoma as in childhood and during adolescence. Utilization of melatonin as an adjuvant with chemotherapeutic drugs for synergy and fortification of the antimetastatic effects for the reinforcement of therapeutic actions are considered.
    URI: http://dx.doi.org/10.1007/s10555-020-09845-2
    https://www.webofscience.com/wos/woscc/full-record/WOS:000517421300001
    https://ir.csmu.edu.tw:8080/handle/310902500/25041
    關聯: CANCER AND METASTASIS REVIEWS ,2020 ,v39 ,issue 1 ,p303-320
    显示于类别:[中山醫學大學研究成果] 其他文獻

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML249检视/开启


    SFX Query

    在CSMUIR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈